Researchers find possible treatment for diabetes nerve damage

10/26/2004 | ABC News

The scientists found the AS-3201 drug fights the underlying cause of nerve damage in diabetic patients by blocking activity of the enzyme aldose reductase, thereby lowering high levels of sorbitol buildup found in diabetes and associated with nerve damage. Dr. Vera Bril of the University of Toronto team said, "An effective disease-modifying treatment is on the horizon."

View Full Article in:

ABC News

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ